Skip to main content
Signal8
Chan Frank profile photo

Frank Chan

CIK: 0002061743

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HAEMONETICS CORP logo
HAE

HAEMONETICS CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • HAEMONETICS CORP logo
    HAE

    HAEMONETICS CORP

    May 15, 2026
    Tax Payment(F)
    Direct
    546 shares at avg. $56.29$31K
  • HAEMONETICS CORP logo
    HAE

    HAEMONETICS CORP

    May 15, 2026
    Award(A)
    Direct
    27.5K shares-
  • HAEMONETICS CORP logo
    HAE

    HAEMONETICS CORP

    May 16, 2025
    Award(A)
    Direct
    5.7K shares-

1-3 of 3

About Chan Frank

Chan Frank (SEC CIK 0002061743) files insider reports with the SEC as EVP, Chief Operating Officer of HAEMONETICS CORP (HAE).

Signal8 holds 3 ownership filings by Chan Frank (1 Form 3, 2 Form 4), filed between Apr 9, 2025 and May 19, 2026. Those filings report 3 transactions, from May 16, 2025 to May 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chan Frank's filings is in BOSTON, MA.

Recent filings by Chan Frank

  • May 15, 2026: Tax withholding of HAE shares (Form 4, code F).
  • May 15, 2026: Grant or award of HAE shares (Form 4, code A).
  • May 16, 2025: Grant or award of HAE shares (Form 4, code A).

Other insiders filing for HAEMONETICS CORP (HAE)

How to read Form 4 transaction codes